24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Licensing
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:41
Facebook, Instagram and Messenger suffer widespread outage
21:07
Israel defense giant Elbit to phase out Chinese vehicles from its fleet
20:16
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
14:41
SpaceX IPO: Record valuation, record expectations, and record uncertainty
More stories
Buzz
Most popular
Daily
Weekly
1
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
2
How Israel’s AI surveillance breakthrough in Iran is reshaping global intelligence
3
Echo: “Employees have become very good at identifying performative culture”
4
Rylo raises $85 million at $500 million valuation, targets $1 billion revenue by 2028
5
Former Microsoft and Tesla security leaders emerge with $35 million for Pi
More news
Licensing
4 stories about Licensing
Israeli roads off-limits to Tesla Cybertruck due to licensing issues
18.07.24
|
Tomer Hadar
Ministry of Transportation holds back approval over bulletproof concerns
“Licensing practices are tilting the market in favor of certain providers against others”
07.05.22
|
James Spiro
Francisco Mingorance, Executive General at CISPE, explains how cloud monopolies are affecting licensing agreements online
Israel to Set Up Fast Track for Licensing Fintech Projects
19.08.19
|
Meir Orbach
According to the Israeli Ministry of Finance, there are currently 2,000 different entities awaiting licensing, many of which are fintech and blockchain companies that need to make only slight adjustments to comply with current regulations
Teva Reaches Confidential Patent Settlement with Neos
27.12.18
|
CTech
The agreement will enable Teva to manufacture and sell a generic version of Neos’ ADHD drug Cotempla as of 2026